These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 25421634

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Meningeal inflammation and cortical demyelination in acute multiple sclerosis.
    Bevan RJ, Evans R, Griffiths L, Watkins LM, Rees MI, Magliozzi R, Allen I, McDonnell G, Kee R, Naughton M, Fitzgerald DC, Reynolds R, Neal JW, Howell OW.
    Ann Neurol; 2018 Dec; 84(6):829-842. PubMed ID: 30362156
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats.
    Gardner C, Magliozzi R, Durrenberger PF, Howell OW, Rundle J, Reynolds R.
    Brain; 2013 Dec; 136(Pt 12):3596-608. PubMed ID: 24176976
    [Abstract] [Full Text] [Related]

  • 7. B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis.
    Reali C, Magliozzi R, Roncaroli F, Nicholas R, Howell OW, Reynolds R.
    Brain Pathol; 2020 Jul; 30(4):779-793. PubMed ID: 32243032
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration.
    James Bates RE, Browne E, Schalks R, Jacobs H, Tan L, Parekh P, Magliozzi R, Calabrese M, Mazarakis ND, Reynolds R.
    Brain; 2022 Dec 19; 145(12):4287-4307. PubMed ID: 35776111
    [Abstract] [Full Text] [Related]

  • 10. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
    Choi SR, Howell OW, Carassiti D, Magliozzi R, Gveric D, Muraro PA, Nicholas R, Roncaroli F, Reynolds R.
    Brain; 2012 Oct 19; 135(Pt 10):2925-37. PubMed ID: 22907116
    [Abstract] [Full Text] [Related]

  • 11. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
    Haider L, Simeonidou C, Steinberger G, Hametner S, Grigoriadis N, Deretzi G, Kovacs GG, Kutzelnigg A, Lassmann H, Frischer JM.
    J Neurol Neurosurg Psychiatry; 2014 Dec 19; 85(12):1386-95. PubMed ID: 24899728
    [Abstract] [Full Text] [Related]

  • 12. Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration.
    van Olst L, Rodriguez-Mogeda C, Picon C, Kiljan S, James RE, Kamermans A, van der Pol SMA, Knoop L, Michailidou I, Drost E, Franssen M, Schenk GJ, Geurts JJG, Amor S, Mazarakis ND, van Horssen J, de Vries HE, Reynolds R, Witte ME.
    Acta Neuropathol; 2021 Jun 19; 141(6):881-899. PubMed ID: 33779783
    [Abstract] [Full Text] [Related]

  • 13. Oxidative injury in multiple sclerosis cerebellar grey matter.
    Kemp K, Redondo J, Hares K, Rice C, Scolding N, Wilkins A.
    Brain Res; 2016 Jul 01; 1642():452-460. PubMed ID: 27086975
    [Abstract] [Full Text] [Related]

  • 14. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment.
    van Wageningen TA, Vlaar E, Kooij G, Jongenelen CAM, Geurts JJG, van Dam AM.
    Acta Neuropathol Commun; 2019 Dec 11; 7(1):206. PubMed ID: 31829283
    [Abstract] [Full Text] [Related]

  • 15. Meningeal and cortical grey matter pathology in multiple sclerosis.
    Popescu BF, Lucchinetti CF.
    BMC Neurol; 2012 Mar 07; 12():11. PubMed ID: 22397318
    [Abstract] [Full Text] [Related]

  • 16. Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis.
    Magliozzi R, Howell OW, Calabrese M, Reynolds R.
    Nat Rev Neurol; 2023 Aug 07; 19(8):461-476. PubMed ID: 37400550
    [Abstract] [Full Text] [Related]

  • 17. The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome.
    Cooze BJ, Dickerson M, Loganathan R, Watkins LM, Grounds E, Pearson BR, Bevan RJ, Morgan BP, Magliozzi R, Reynolds R, Neal JW, Howell OW.
    Brain Pathol; 2022 Sep 07; 32(5):e13054. PubMed ID: 35132719
    [Abstract] [Full Text] [Related]

  • 18. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis.
    Kooi EJ, Geurts JJ, van Horssen J, Bø L, van der Valk P.
    J Neuropathol Exp Neurol; 2009 Sep 07; 68(9):1021-8. PubMed ID: 19680141
    [Abstract] [Full Text] [Related]

  • 19. Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter.
    Picon C, Jayaraman A, James R, Beck C, Gallego P, Witte ME, van Horssen J, Mazarakis ND, Reynolds R.
    Acta Neuropathol; 2021 Apr 07; 141(4):585-604. PubMed ID: 33569629
    [Abstract] [Full Text] [Related]

  • 20. "Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis.
    Magliozzi R, Fadda G, Brown RA, Bar-Or A, Howell OW, Hametner S, Marastoni D, Poli A, Nicholas R, Calabrese M, Monaco S, Reynolds R.
    Ann Neurol; 2022 Oct 07; 92(4):670-685. PubMed ID: 35748636
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.